Scilex Holding (SCLXW) Return on Sales (2022 - 2026)
Scilex Holding (SCLXW) recorded quarterly Return on Sales of 0.05% in Q1 2026, up 44.28% quarter-over-quarter from 0.1% in Q4 2025, and little changed on a YoY basis from 0.05% in Q1 2025.
Scilex Holding (SCLXW) Return on Sales (2022 - 2026) Analysis & Trends
Scilex Holding's Return on Sales history runs 5 years deep, the most recent figure standing at 0.05% for Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.05%; the TTM figure through Mar 2026 stood at 0.12% (down 10.0% YoY), while the FY2025 annual figure was 0.12%, down 11.0% from the prior year.
- Return on Sales was 0.05% for Q1 2026 at Scilex Holding, up from 0.1% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.02% in Q3 2022 to a low of 0.24% in Q3 2025.
- Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.02% in 2022.
- The sharpest annual moves came in 2024 and 2025: Return on Sales increased 3 bps in 2024, then retreated 24 bps in 2025.
- A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then retreated by 6 bps to 0.02% in 2023, then surged by 73 bps to 0.0% in 2024, then plunged by 2097 bps to 0.1% in 2025, then soared by 44 bps to 0.05% in 2026.
- The last three Return on Sales figures came in at 0.05% (Q1 2026), 0.1% (Q4 2025), and 0.24% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.00% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.00% |
| 10 | Scilex Holding | - | - | 4.15 Mn | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | -0.10% |
| Sep 30, 2025 | -0.24% |
| Jun 30, 2025 | -0.04% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |